The health and safety of our employees, patients, customers and communities is our top priority. Read about our response to COVID-19

Inspire Medical Systems, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference

Download as PDF

MINNEAPOLIS, MN – January 7, 2020 – Inspire Medical Systems, Inc. (NYSE: INSP)
(Inspire), a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea, announced today that its management team will be presenting
at the 38th Annual J.P. Morgan Healthcare Conference on January 16, 2020, at the
Westin St. Francis Hotel in San Francisco.

Inspire is scheduled to present at 11:30 a.m. Pacific Time. The presentation will be
accessible via a live webcast at:
https://jpmorgan.metameetings.net/events/hc20/sessions/30560-inspire-medical-
systems-inc/webcast

A webcast replay of the presentation will be available for two weeks following the
presentation in the Event Archive section of Inspire’s Investor website at
https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-
approved neurostimulation technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989